"Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
| Descriptor ID |
D014612
|
| MeSH Number(s) |
D20.215.894
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Vaccines".
This graph shows the total number of publications written about "Vaccines" by people in this website by year, and whether "Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 1 | 3 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 3 | 1 | 4 |
| 2015 | 6 | 3 | 9 |
| 2016 | 9 | 1 | 10 |
| 2017 | 89 | 30 | 119 |
| 2018 | 102 | 36 | 138 |
| 2019 | 44 | 17 | 61 |
| 2020 | 32 | 16 | 48 |
| 2021 | 160 | 9 | 169 |
| 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vaccines" by people in Profiles.
-
Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies. Haematologica. 2022 03 01; 107(3):715-720.
-
Interpreting Prevention of COVID-19 and Vaccines. J Infect Dis. 2022 02 15; 225(4):741.
-
Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients. Transplantation. 2021 12 01; 105(12):e282.
-
Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. Haematologica. 2021 12 01; 106(12):3034-3045.
-
ImmTORTM to amplify the efficacy and reduce immunogenicity of biologics. Emerg Top Life Sci. 2021 11 12; 5(5):597-600.
-
Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load. Epidemiology. 2021 11 01; 32(6):820-828.
-
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. Eur Heart J. 2021 10 14; 42(39):4064-4072.
-
Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink. JAMA. 2021 10 12; 326(14):1375-1377.
-
Interactive, on-line visualization tools to measure and drive equity in COVID-19 vaccine administrations. J Am Med Inform Assoc. 2021 10 12; 28(11):2451-2455.
-
COVID-19 vaccine hesitancy among patients in two urban emergency departments. Acad Emerg Med. 2021 10; 28(10):1100-1107.